Evidence map›Paper›PMID 39420905›Full record

ArticleArchives of endocrinology and metabolism2024

A case series of maturity-onset diabetes of the young highlighting atypical presentations and the implications of genetic diagnosis.

Meghana Narasimhegowda, Vani Hebbal Nagarajappa, Raghupathy Palany

Abstract readCase Reports
In one paragraph

Article in Archives of endocrinology and metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Meghana NarasimhegowdaDivision of Pediatric and Adolescent Endocrinology Indira Gandhi Institute of Child Health Bengaluru India Division of Pediatric and Adolescent Endocrinology, Indira Gandhi Institute of Child Health, Bengaluru, India.ORCID https://orcid.org/0000-0002-3871-4442
Vani Hebbal NagarajappaDivision of Pediatric and Adolescent Endocrinology Indira Gandhi Institute of Child Health Bengaluru India Division of Pediatric and Adolescent Endocrinology, Indira Gandhi Institute of Child Health, Bengaluru, India.ORCID https://orcid.org/0000-0002-8320-0897
Raghupathy PalanyDivision of Pediatric and Adolescent Endocrinology Indira Gandhi Institute of Child Health Bengaluru India Division of Pediatric and Adolescent Endocrinology, Indira Gandhi Institute of Child Health, Bengaluru, India.ORCID https://orcid.org/0000-0002-7448-586X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maturity-onset diabetes of the young (MODY) is a clinically heterogeneous group of monogenic diabetes characterized by onset at a young age and an autosomal dominant mode of inheritance. Notably, MODY accounts for 2%-5% of all diabetes cases, and its distinction from types 1 (T1DM) and 2 (T2DM) diabetes mellitus is often challenging. We report herein the cases of two girls and a boy who presented initially with diabetic ketoacidosis. In view of the strong family history of diabetes in all three of them, the diagnosis of MODY was considered and confirmed by molecular testing. The patient in Case 1 (a 10-year-old girl) had a variation in the HNF1A gene (MODY 3). The patient in Case 2 (a 13-year-old girl) had a variation in the HNF1B gene (MODY 5) and was also clinically diagnosed with HNF1B MODY due to short stature, abnormal renal function, renal cysts, unicornuate uterus, and diabetic ketoacidosis at presentation. The patient in Case 3 (a 14-year-old boy) had a variation in the KCNJ11 gene (MODY 13) and presented with diabetic ketoacidosis; after initially being treated as having T1DM, he developed progressive weight gain, acanthosis nigricans, and decreased requirement of insulin. The patients in Cases 1 and 3 were subsequently treated with oral sulfonylureas and insulin was gradually tapered and interrupted, resulting in drastic improvement in glucose control. The patient in Case 2 remained on insulin, as this is the appropriate management for MODY 5. This case series demonstrates that atypical cases of MODY with ketoacidosis do occur, underscoring the potential for this complication within the phenotypic spectrum of MODY. In patients with atypical presentations, a thorough family history taking may reveal the diagnosis of MODY.

Indexed as

Diabetes Mellitus, Type 2Hepatocyte Nuclear Factor 1-alphaHepatocyte Nuclear Factor 1-betaAdolescentChildDiabetic KetoacidosisFemaleGenetic TestingHumansMaleHepatocyte Nuclear Factor 1-alphaHepatocyte Nuclear Factor 1-betaHNF1A protein, humanHNF1B protein, human

Identifiers

PMID39420905
PMCPMC11326734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.